Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.08	0.1	0.01	0.08	0.1	0.04
Revenue Growth (YoY)	105.00%	653.85%	-83.95%	-20.59%	183.33%	-36.84%
Cost of Revenue	0.1	0.15	0.08	0.06	0.04	0.07
Gross Profit	-0.02	-0.05	-0.07	0.02	0.06	-0.03
Selling, General & Admin	2.68	3.18	3.19	2.31	1.05	0.78
Research & Development	0.28	0.23	0.08	0.07	0.14	0.12
Other Operating Expenses	0.04	0.04	0.02	0.51	0.27	0.05
Operating Expenses	2.95	3.41	3.27	2.38	1.2	0.9
Operating Income	-2.97	-3.46	-3.33	-2.36	-1.05	-0.94
Interest Income	0.08	0.01	0.58	1.15	1.06	1.41
Interest Expense	0.28	0.28	0.58	1.15	1.06	1.41
Other Expense / Income	-0.3	-0.51	1.01	-0.29	-0.77	0.98
Pretax Income	-3.02	-3.49	-4.34	-2.07	-0.28	-1.92
Income Tax	0.15	0.27	0.63	1.66	1.06	1.46
Net Income	-3.02	-3.49	-4.97	-3.73	-1.34	-3.38
Shares Outstanding (Basic)	55	51	33	13	11	3
Shares Outstanding (Diluted)	55	51	33	13	11	3
Shares Change	11.06%	57.30%	142.99%	24.24%	226.08%	-94.94%
EPS (Basic)	-0.06	-0.07	-0.15	-0.28	-0.12	-1.02
EPS (Diluted)	-0.06	-0.07	-0.15	-0.28	-0.12	-1.02
Free Cash Flow	-1.35	-1.75	-1.51	-1.61	-1.88	-0.81
Free Cash Flow Per Share	-0.02	-0.03	-0.05	-0.12	-0.17	-0.24
Gross Margin	-22.02%	-50.00%	-523.08%	24.69%	59.80%	-94.44%
Operating Margin	-3624.39%	-3527.55%	-25638.46%	-2916.05%	-1031.37%	-2602.78%
Profit Margin	-3685.37%	-3560.20%	-38246.15%	-4601.23%	-1308.82%	-9391.67%
Free Cash Flow Margin	-1642.68%	-1781.63%	-11607.69%	-1982.72%	-1839.22%	-2238.89%
EBITDA	-2.88	-3.37	-3.25	-1.77	-0.78	-0.87
EBITDA Margin	-3517.01%	-3440.82%	-24961.54%	-2187.65%	-765.69%	-2411.11%
Depreciation & Amortization	0.09	0.09	0.07	0.08	0	0.02
EBIT	-2.97	-3.46	-3.32	-1.86	-	-0.89
EBIT Margin	-3624.39%	-3527.55%	-25515.38%	-2290.12%	-	-2469.44%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.